Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL Meeting Abstract


Authors: Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019002119
PROVIDER: wos
DOI: 10.1182/blood.V126.23.682.682
Notes: Meeting Abstract: 682 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Kevin Joseph Curran
    148 Curran
  3. Jae Hong Park
    356 Park
  4. Craig Steven Sauter
    334 Sauter
  5. Elizabeth F Halton
    53 Halton
  6. Michel W J Sadelain
    583 Sadelain
  7. Isabelle C Riviere
    240 Riviere
  8. Xiuyan Wang
    119 Wang
  9. Yvette J Bernal
    32 Bernal
  10. Terence John Purdon
    61 Purdon
  11. Yongzeng   Wang
    19 Wang